Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

25.49

+0.93 (3.79%)

At close: Aug 19, 2026, 4:00 PM EDT

25.99

+0.50 (1.96%)

After-hours: Aug 19, 2026, 7:43 PM EDT

Adaptive Biotechnologies Employees

Adaptive Biotechnologies had 624 employees as of December 31, 2025. The number of employees increased by 5 or 0.81% compared to the previous year.

Employees

624

Change (1Y)

5

Growth (1Y)

0.81%

Revenue / Employee

$493,720

Profits / Employee

-$102,330

Market Cap

4.07B

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	624	5	0.81%
Dec 31, 2024	619	-90	-12.69%
Dec 31, 2023	709	-81	-10.25%
Dec 31, 2022	790	-68	-7.93%
Dec 31, 2021	858	236	37.94%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
RadNet	9,276
Qiagen	5,700
Sotera Health Company	3,000
NeoGenomics	2,500
GeneDx Holdings	1,300
Twist Bioscience	979
GRAIL	910
CareDx	765

Employee Rankings

ADPT News

2 days ago - Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science - GeekWire
15 days ago - Adaptive Biotechnologies price target raised to $27.50 from $20 at Piper Sandler - TheFly
20 days ago - Adaptive Biotechnologies price target raised to $27 from $25 at JPMorgan - TheFly
20 days ago - Adaptive Biotechnologies price target raised to $22 from $20 at Morgan Stanley - TheFly
20 days ago - Adaptive Biotechnologies price target raised to $25 from $24 at BTIG - TheFly
20 days ago - Adaptive Biotechnologies price target raised to $28 from $25 at TD Cowen - TheFly
20 days ago - Adaptive Biotechnologies price target raised to $25 from $22 at Guggenheim - TheFly
21 days ago - Adaptive Biotechnologies reports Q2 EPS (25c), consensus (13c) - TheFly